Steven R. Cummings | Academic Influence

Steven R. Cummings's AcademicInfluence.com Rankings

Steven R. Cummings

Medical

#479

World Rank

#655

Historical Rank

Epidemiology

#46

World Rank

#52

Historical Rank

medical Degrees

Download Badge

Medical

Steven R. Cummings's Degrees

Bachelors Biology University of California, Berkeley
PhD Epidemiology Johns Hopkins University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Steven R. Cummings Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Steven R. Cummings is an American epidemiologist and Emeritus Professor of Medicine, Epidemiology and Biostatistics at the University of California San Francisco. He is one of the top highly cited researchers according to webometrics.

(See a Problem?)

Steven R. Cummings's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures (1996) (3767)
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. (1995) (3667)
Epidemiology and outcomes of osteoporotic fractures (2002) (3410)
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. (1999) (2724)
Bone density at various sites for prediction of hip fractures (1993) (2468)
Hormone therapy to prevent disease and prolong life in postmenopausal women (1992) (2372)
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. (1998) (2314)
Denosumab for prevention of fractures in postmenopausal women with osteoporosis. (2009) (2299)
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. (1998) (2280)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (2007) (2189)
Risk factors for recurrent nonsyncopal falls. A prospective study. (1989) (1859)
Calcium plus vitamin D supplementation and the risk of fractures. (2006) (1778)
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. (1999) (1638)
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. (2006) (1330)
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. (2003) (1166)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (2007) (1115)
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. (2003) (1056)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture (2012) (1045)
Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. (1999) (1012)
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. (2000) (977)
Risk factors for injurious falls: a prospective study. (1991) (971)
Epidemiology of osteoporosis and osteoporotic fractures. (1985) (945)
BMD at Multiple Sites and Risk of Fracture of Multiple Types: Long‐Term Results From the Study of Osteoporotic Fractures (2003) (943)
Appendicular Bone Density and Age Predict Hip Fracture in Women (1990) (928)
Designing Clinical Research: An Epidemiologic Approach (1988) (907)
Sarcopenia with limited mobility: an international consensus. (2011) (848)
Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. (2008) (840)
Estrogen Replacement Therapy and Fractures in Older Women (1995) (814)
The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study (1998) (804)
Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures (1999) (795)
Clinical use of bone densitometry: scientific review. (2002) (779)
Older women with diabetes have an increased risk of fracture: a prospective study. (2001) (772)
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. (2001) (751)
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial (2000) (746)
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies (2012) (745)
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial (2009) (737)
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. (2002) (726)
Secular trends in the incidence of hip and other osteoporotic fractures (2011) (717)
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. (2005) (684)
Simple measurement of femoral geometry predicts hip fracture: The study of osteoporotic fractures (1993) (679)
Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. (1989) (677)
Forgetting Falls (1988) (634)
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. (2004) (633)
The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. (1990) (628)
Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. (1990) (603)
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis (1996) (592)
The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT) (2011) (588)
Physical performance measures in aging research. (1989) (577)
Older women with diabetes have a higher risk of falls: a prospective study. (2002) (565)
Factors Associated with Appendicular Bone Mass in Older Women (1993) (560)
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. (2001) (556)
A Comparison of Frailty Indexes for the Prediction of Falls, Disability, Fractures, and Mortality in Older Men (2009) (543)
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. (2017) (535)
Which Fractures Are Associated with Low Appendicular Bone Mass in Elderly Women (1991) (529)
Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. (2000) (525)
Axial and appendicular bone density predict fractures in older women (1992) (503)
Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. (2006) (501)
Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. (1998) (496)
Thiazolidinedione use and bone loss in older diabetic adults. (2006) (496)
Contribution of vertebral deformities to chronic back pain and disability (1992) (494)
Relationship Between Osteoporosis and Cardiovascular Disease in Postmenopausal Women (2005) (493)
Biology of Aging (2007) (478)
Ultrasonography versus computed tomography for suspected nephrolithiasis. (2014) (477)
Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model (2008) (475)
Risk factors for fractures of the distal forearm and proximal humerus. The Study of Osteoporotic Fractures Research Group. (1992) (461)
TYPE OF FALL AND RISK OF HIP AND WRIST FRACTURES: THE STUDY OF OSTEOPOROTIC FRACTURES (1993) (460)
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension (2018) (434)
Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer (1999) (433)
CLINICAL USE OF BONE DENSITOMETRY (1991) (417)
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. (2005) (416)
Non-trauma mortality in elderly women with low bone mineral density (1991) (411)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data (2013) (398)
Relationship of changes in physical activity and mortality among older women. (2003) (395)
The effects of tibolone in older postmenopausal women. (2008) (386)
Type of Fall and Risk of Hip and Wrist Fractures: The Study of Osteoporotic Fractures (1993) (386)
A hypothesis: the causes of hip fractures. (1989) (383)
Endogenous Hormones and the Risk of Hip and Vertebral Fractures Among Older Women (1999) (371)
Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fractures (1995) (364)
Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. (1995) (360)
Do Muscle Mass, Muscle Density, Strength, and Physical Function Similarly Influence Risk of Hospitalization in Older Adults? (2009) (359)
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies (2011) (351)
Age‐related decrements in bone mineral density in women over 65 (1992) (351)
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (2019) (350)
A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women. Study of Osteoporotic Fractures Research Group. (2001) (340)
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity (2009) (330)
Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness (2011) (325)
Computed Tomographic Measurements of Thigh Muscle Cross-Sectional Area and Attenuation Coefficient Predict Hip Fracture: The Health, Aging, and Body Composition Study (2009) (321)
The cost-effectiveness of counseling smokers to quit. (1989) (319)
High-trauma fractures and low bone mineral density in older women and men. (2007) (314)
Intentional and Unintentional Weight Loss Increase Bone Loss and Hip Fracture Risk in Older Women (2003) (306)
Effects of denosumab on fracture and bone mineral density by level of kidney function (2011) (301)
Evaluation of two food frequency methods of measuring dietary calcium intake. (1987) (292)
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. (1999) (289)
Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. (1998) (281)
Pentosidine and increased fracture risk in older adults with type 2 diabetes. (2009) (281)
Postmenopausal osteoporosis (2016) (278)
Continuing bisphosphonate treatment for osteoporosis--for whom and for how long? (2012) (273)
Structural Adaptation to Changing Skeletal Load in the Progression Toward Hip Fragility: The Study of Osteoporotic Fractures (2001) (270)
Long‐Term Prediction of Incident Hip Fracture Risk in Elderly White Women: Study of Osteoporotic Fractures (2004) (269)
Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures (2008) (268)
Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial (2007) (268)
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization (2014) (260)
Bone Mineral Density and Risk of Breast Cancer in Older Women: The Study of Osteoporotic Fractures (1996) (260)
Incident vertebral fractures and mortality in older women: a prospective study (2003) (259)
Prediction of Incident Hip Fracture Risk by Femur Geometry Variables Measured by Hip Structural Analysis in the Study of Osteoporotic Fractures (2008) (256)
Finite Element Analysis of the Proximal Femur and Hip Fracture Risk in Older Men (2009) (256)
Rate of Bone Loss Is Associated with Mortality in Older Women: A Prospective Study (2000) (256)
Renal function and risk of hip and vertebral fractures in older women. (2007) (256)
Fetuin-A and incident diabetes mellitus in older persons. (2008) (256)
The accuracy of self-report of fractures in elderly women: evidence from a prospective study. (1992) (256)
A new approach to defining normal vertebral dimensions (1991) (255)
Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures (1995) (249)
Monitoring Osteoporosis Therapy With Bone Densitometry: Misleading Changes and Regression to the Mean (2000) (246)
New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk (2016) (242)
Bone mineral density and the risk of incident nonspinal fractures in black and white women. (2005) (242)
Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. (1996) (242)
Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study (2005) (241)
The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension (2013) (240)
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations (2000) (236)
Prediction of hip fractures from pelvic radiographs: The study of osteoporotic fractures (1994) (234)
Inflammatory Markers and Incident Fracture Risk in Older Men and Women: The Health Aging and Body Composition Study (2007) (231)
Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. (2009) (231)
Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. (1996) (231)
Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women (2011) (230)
Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population (2005) (227)
Testosterone and estradiol among older men. (2006) (227)
Long-term risk of incident vertebral fractures. (2007) (225)
Alendronate and atrial fibrillation. (2007) (224)
Effects of Ultralow-Dose Transdermal Estradiol on Bone Mineral Density: A Randomized Clinical Trial (2004) (224)
Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. (2013) (221)
BMD and Risk of Hip and Nonvertebral Fractures in Older Men:A Prospective Study and Comparison With Older Women (2006) (221)
Very low rates of hip fracture in Beijing, People's Republic of China the Beijing Osteoporosis Project. (1996) (220)
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. (2009) (219)
Osteoporosis: the evolution of a diagnosis (2015) (219)
Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. (2005) (218)
Are patients with hip fractures more osteoporotic? Review of the evidence. (1985) (217)
Risk Factors for a First‐Incident Radiographic Vertebral Fracture in Women ≥65 Years of Age: The Study of Osteoporotic Fractures (2004) (217)
A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation (2012) (216)
The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT) (2015) (213)
Fracture risk in diabetic elderly men: the MrOS study (2014) (213)
Mortality Following Fractures in Older Women: The Study of Osteoporotic Fractures (1996) (209)
Actigraphy-measured sleep characteristics and risk of falls in older women. (2008) (209)
Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. (2010) (209)
Should perimenopausal women be screened for osteoporosis? (1986) (208)
Epidemiology of hip fractures. (1997) (207)
Racial differences in hip axis lengths might explain racial differences in rates of hip fracture (1994) (207)
Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: A longitudinal study (1999) (206)
Reproductive correlates of bone mass in elderly women (1993) (206)
Meta-Analysis of Genome-Wide Association Studies in African Americans Provides Insights into the Genetic Architecture of Type 2 Diabetes (2014) (205)
Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. (2000) (203)
Serum estradiol level and risk of breast cancer during treatment with raloxifene. (2002) (203)
Body Size and Hip Fracture Risk in Older Women: A Prospective Study (1997) (201)
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. (2009) (200)
Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. (2005) (200)
Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Study of Osteoporotic Fractures Research Group. (1999) (197)
Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program. (1989) (196)
Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach. (1986) (196)
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. (2007) (193)
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis (2011) (193)
Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. (2002) (193)
Proximal Femoral Structure and the Prediction of Hip Fracture in Men: A Large Prospective Study Using QCT (2008) (191)
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition. (2002) (189)
A diagnosis of dismobility--giving mobility clinical visibility: a Mobility Working Group recommendation. (2014) (189)
Association Between Low Bone Density and Stroke in Elderly Women: The Study of Osteoporotic Fractures (1993) (188)
Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study (2008) (188)
Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. (2011) (187)
Weight Change and Fractures in Older Women (1997) (187)
Tibolone for postmenopausal women: systematic review of randomized trials. (2002) (185)
Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. (2007) (185)
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. (1999) (184)
Comparison of methods to measure low serum estradiol levels in postmenopausal women. (2006) (184)
Osteoporosis: association of recent fractures with quantitative US findings. (1996) (181)
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial (2010) (181)
Defining Incident Vertebral Deformity: A Prospective Comparison of Several Approaches (1999) (179)
Hormonal Predictors of Bone Loss in Elderly Women: A Prospective Study (1998) (178)
Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. (1992) (176)
Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. (1995) (175)
Endogenous testosterone levels, physical performance, and fall risk in older men. (2006) (175)
Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. (1995) (175)
Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2‐year results from a randomized trial (2011) (173)
Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures (1999) (172)
Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans (2012) (171)
Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. (2003) (170)
Calcium intake and fracture risk: results from the study of osteoporotic fractures. (1997) (170)
Results of bone densitometry affect women's decisions about taking measures to prevent fractures. (1992) (170)
Occupational exposure to HIV: frequency and rates of underreporting of percutaneous and mucocutaneous exposures by medical housestaff. (1991) (169)
Non-skeletal determinants of fractures: the potential importance of the mechanics of falls (2005) (168)
Recovery of Function After Hip Fracture The Role of Social Supports (1988) (168)
A comparison of prediction models for fractures in older women: is more better? (2009) (167)
Predictors of Non‐Spine Fracture in Elderly Men: The MrOS Study (2006) (166)
Mammographic density and risk of breast cancer by age and tumor characteristics (2013) (165)
Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. (2005) (165)
Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. (2004) (165)
Correlates of Impaired Function in Older Women (1994) (164)
The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS) (2009) (163)
Classification of Osteoporosis Based on Bone Mineral Densities (2001) (162)
Effects of Thiazide Diuretic Therapy on Bone Mass, Fractures, and Falls (1993) (162)
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates (2016) (161)
Rapidly increasing rates of hip fracture in Beijing, China (2012) (161)
A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women 1 – 3 (2000) (161)
Warfarin Use and Risk for Osteoporosis in Elderly Women (1998) (160)
Volume of Mammographic Density and Risk of Breast Cancer (2011) (159)
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. (2007) (159)
Low Fractional Calcium Absorption Increases the Risk for Hip Fracture in Women with Low Calcium Intake (2000) (158)
A meta-analysis of genome-wide association studies identifies multiple longevity genes (2019) (158)
Use of alendronate and risk of incident atrial fibrillation in women. (2008) (158)
Safety and Adverse Effects Associated With Raloxifene: Multiple Outcomes of Raloxifene Evaluation (2004) (157)
Lasofoxifene in postmenopausal women with osteoporosis. (2010) (156)
Hip fracture and increased short-term but not long-term mortality in healthy older women. (2011) (156)
Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study. (2005) (155)
High blood cholesterol in elderly men and the excess risk for coronary heart disease. (1990) (154)
Diabetes and Bone Loss at the Hip in Older Black and White Adults (2004) (152)
Five Years of Cenosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the First Two Years of the FREEDOM Extension (2011) (152)
Phytoestrogen Supplements for the Treatment of Hot Flashes: The Isoflavone Clover Extract (ICE) Study: A Randomized Controlled Trial (2003) (151)
Validation of an armband to measure daily energy expenditure in older adults. (2011) (151)
Telomere length and cognitive function in community-dwelling elders: Findings from the Health ABC Study (2011) (150)
Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. (2007) (149)
Higher risk of multiple falls among elderly women who lose visual acuity. (2004) (148)
Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group. (1997) (148)
Optimum cutoff points for biochemical validation of smoking status. (1988) (147)
Circulating 25-hydroxyvitamin D levels and frailty status in older women. (2010) (147)
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures (2012) (146)
Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. (1997) (145)
Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic Fractures (2003) (143)
Correlates of Kyphosis in Older Women (1997) (141)
Serum 25-Hydroxyvitamin D and the Risk of Hip and Nonspine Fractures in Older Men (2009) (141)
Vertebral Fractures in Beijing, China: The Beijing Osteoporosis Project (2000) (140)
Physical Performance and Risk of Hip Fractures in Older Men (2008) (140)
Lipid-lowering drug use and breast cancer in older women: a prospective study. (2003) (139)
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis (2012) (138)
Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. (2004) (138)
Smoking, alcohol, and neuromuscular and physical function of older women. Study of Osteoporotic Fractures Research Group. (1994) (137)
Self‐Reported Sleep and Nap Habits and Risk of Falls and Fractures in Older Women: The Study of Osteoporotic Fractures (2006) (137)
Treatment failure in osteoporosis (2012) (136)
Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT) (2003) (135)
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. (2010) (133)
Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk--The Study of Osteoporotic Fractures. (1999) (131)
Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study. (2014) (131)
Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. (2007) (131)
Intermittent Use of Nitrates Increases Bone Mineral Density: The Study of Osteoporotic Fractures (1998) (130)
Self‐Reported Sleep and Nap Habits and Risk of Mortality in a Large Cohort of Older Women (2009) (130)
Mortality following fractures in older women. The study of osteoporotic fractures. (1997) (129)
Does estimating volumetric bone density of the femoral neck improve the prediction of hip fracture? A prospective study (1994) (128)
Hyperkyphosis Predicts Mortality Independent of Vertebral Osteoporosis in Older Women (2009) (128)
The effect of raloxifene treatment in postmenopausal women with CKD. (2008) (128)
Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2017) (127)
The determinants of bone mineral density in Chinese men—results from Mr. Os (Hong Kong), the first cohort study on osteoporosis in Asian men (2006) (127)
Correlates of impaired function in older women. (1995) (127)
Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF (2013) (127)
Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial (2005) (127)
Mammographic density and estrogen receptor status of breast cancer. (2004) (125)
A comparison of morphometric definitions of vertebral fracture (1991) (123)
Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study (2007) (123)
Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). (2001) (122)
Automated evaluation of hip axis length for predicting hip fracture (1994) (122)
Family History and Risk of Osteoporotic Fracture (1998) (120)
Modifiable Risk Factors Predict Functional Decline Among Older Women: A Prospectively Validated Clinical Prediction Tool (2000) (120)
Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS) (2016) (119)
Strong Relation Between Muscle Mass Determined by D3-creatine Dilution, Physical Performance, and Incidence of Falls and Mobility Limitations in a Prospective Cohort of Older Men. (2018) (117)
Goal‐Directed Treatment for Osteoporosis: A Progress Report From the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis (2017) (116)
Postural Hypotension and Postural Dizziness in Elderly Women: The Study of Osteoporotic Fractures (1992) (116)
The senescence-associated secretome as an indicator of age and medical risk. (2020) (114)
Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON‐PFT, and FREEDOM trials (2013) (114)
Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort (2007) (114)
Body Composition Remodeling and Mortality: The Health Aging and Body Composition Study (2016) (113)
Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study. (2004) (112)
Alcohol Intake and Its Relationship with Bone Mineral Density, Falls, and Fracture Risk in Older Men (2006) (112)
Kyphosis in older women and its relation to back pain, disability and osteopenia: The study of osteoporotic fractures (2006) (112)
Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene (2006) (111)
Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. (2010) (111)
Interactive Informed Consent: Randomized Comparison with Paper Consents (2013) (110)
Breast cancer risk prediction using a clinical risk model and polygenic risk score (2016) (110)
A comparison of morphometric definitions of vertebral fracture. (1991) (110)
Rheumatoid arthritis and bone mineral density in elderly women (1995) (110)
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms (2017) (110)
Design of the Fracture Intervention Trial (2005) (109)
Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. (2009) (109)
An Internet-Based Randomized, Placebo-Controlled Trial of Kava and Valerian for Anxiety and Insomnia (2005) (109)
Effects of Current and Discontinued Estrogen Replacement Therapy on Hip Structural Geometry: The Study of Osteoporotic Fractures * (2001) (107)
Binocular Visual‐Field Loss Increases the Risk of Future Falls in Older White Women (2007) (106)
Factors associated with kyphosis progression in older women: 15 years' experience in the study of osteoporotic fractures (2013) (106)
Shorter telomeres are associated with obesity and weight gain in the elderly (2012) (106)
Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men (2009) (105)
Impact of seafood and fruit consumption on bone mineral density. (2007) (105)
Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. (2001) (105)
Are breast density and bone mineral density independent risk factors for breast cancer? (2005) (105)
The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. (2003) (105)
Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study. (2009) (104)
Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study. (2008) (103)
Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study (2015) (103)
Kidney Function and Cognitive Performance and Decline in Older Men (2008) (103)
Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. (1997) (102)
Serum sclerostin and risk of hip fracture in older Caucasian women. (2012) (102)
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. (2011) (102)
1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial. (1991) (101)
Managing solitary pulmonary nodules. The choice of strategy is a "close call". (1986) (100)
Evidence for geographical and racial variation in serum sex steroid levels in older men. (2010) (99)
Femoral Neck and Intertrochanteric Fractures Have Different Risk Factors: A Prospective Study (2000) (98)
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. (2012) (97)
Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population-based study (2005) (97)
WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis? (2011) (97)
Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. (2006) (96)
Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women (2011) (96)
Diabetes and Risk of Hospitalized Fall Injury Among Older Adults (2013) (96)
Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group. (1999) (95)
Clinical use of bone densitometry: clinical applications. (2002) (94)
D3‐Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass (2019) (93)
Appendicular bone mineral and a woman's lifetime risk of hip fracture (1992) (91)
Bone mineral density predicts non-spine fractures in very elderly women (1994) (91)
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. (2009) (91)
REST/ACTIVITY RHYTHMS AND MORTALITY RATES IN OLDER MEN: MROS SLEEP STUDY (2010) (90)
FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial (2009) (90)
Bone mass and breast cancer risk in older women: differences by stage at diagnosis. (2001) (89)
Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong) (2005) (89)
Adipose tissue density, a novel biomarker predicting mortality risk in older adults. (2014) (87)
Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men (2009) (87)
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. (2014) (86)
Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial. (2014) (86)
An examination of the association between vertebral deformities, physical disabilities and psychosocial problems. (1988) (86)
Homocysteine levels and risk of hip fracture in postmenopausal women. (2009) (86)
Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study (2009) (85)
Isosorbide Mononitrate Increases Bone Formation and Decreases Bone Resorption in Postmenopausal Women: A Randomized Trial (2004) (85)
Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. (1992) (85)
Circadian Activity Rhythms and Mortality: The Study of Osteoporotic Fractures (2010) (85)
Recommendations for Optimal Care of the Fragility Fracture Patient to Reduce the Risk of Future Fracture (2004) (84)
Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults. (2010) (84)
The association of Parkinson’s disease with bone mineral density and fracture in older women (2008) (84)
Loss of Hip BMD in Older Men: The Osteoporotic Fractures in Men (MrOS) Study (2009) (82)
Estrogen receptor genotype and risk of cognitive impairment in elders: Findings from the Health ABC study (2009) (81)
Nulliparity and Fracture Risk in Older Women: The Study of Osteoporotic Fractures (2003) (80)
Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines (2009) (80)
Prevalence of Osteoporosis and Fracture in China (2021) (80)
Hospitalization and Change in Body Composition and Strength in a Population‐Based Cohort of Older Persons (2010) (79)
The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. (2020) (79)
Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. (2009) (78)
Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study (2009) (78)
Novel use of Single X-Ray Absorptiometry for Measuring Breast Density (2005) (78)
Establishing the Link Between Lean Mass and Grip Strength Cut-points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference. (2019) (77)
Frailty Phenotype and Healthcare Costs and Utilization in Older Women (2018) (77)
Treatable and untreatable risk factors for hip fracture. (1996) (77)
Serum adiponectin and coronary heart disease risk in older Black and White Americans. (2006) (76)
Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. (2002) (76)
Is Postmenopausal Estrogen Therapy Associated With Neuromuscular Function or Falling in Elderly Women (1995) (76)
Lifestyle predicts falls independent of physical risk factors (2009) (75)
Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials. (2003) (75)
Heterogeneity of age-related fractures: implications for epidemiology. (1987) (75)
The genetics of human longevity. (2004) (75)
Correlates of kyphosis in older women. The Fracture Intervention Trial Research Group. (1997) (74)
The QT interval and risk of incident atrial fibrillation. (2013) (74)
Snoring, daytime sleepiness, and incident cardiovascular disease in the health, aging, and body composition study. (2013) (74)
Comparison between southern blots and qPCR analysis of leukocyte telomere length in the health ABC study. (2014) (74)
Measurement of breast density with dual X-ray absorptiometry: feasibility. (2002) (73)
Effect of Raloxifene on the Incidence of Invasive Breast Cancer in Postmenopausal Women with Osteoporosis Categorized by Breast Cancer Risk (2006) (73)
Do statins prevent both cardiovascular disease and fracture? (2000) (72)
Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women. (2008) (72)
Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. (2000) (71)
Olfaction and risk of dementia in a biracial cohort of older adults (2017) (71)
Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. (2015) (71)
Dual X‐ray absorptiometry quality control: Comparison of visual examination and process‐control charts (1996) (71)
Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. (2009) (71)
Clinical utility of laboratory testing in women with osteoporosis (2005) (70)
Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report (1998) (70)
Cystatin‐C, Renal Function, and Incidence of Hip Fracture in Postmenopausal Women (2008) (70)
Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). (2006) (69)
Association between aortic calcification and total and cardiovascular mortality in older women (2007) (68)
Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study. (2006) (66)
Association of the G‐174C Variant in the Interleukin‐6 Promoter Region With Bone Loss and Fracture Risk in Older Women (2004) (66)
Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. (2011) (66)
Serum calcium, phosphorus and cardiovascular events in post-menopausal women. (2011) (66)
Estrogen Metabolites and the Risk of Breast Cancer in Older Women (2003) (65)
A normative reference database study for Pronosco X-posure System. (2001) (65)
Hip fractures attributable to corticosteroid use (1999) (64)
Appendicular bone mineral and a woman's lifetime risk of hip fracture. (1992) (64)
Identification of Vertebral Fracture and Non‐Osteoporotic Short Vertebral Height in Men: The MrOS Study (2007) (64)
Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Study of Osteoporotic Fractures Research Group. (1995) (64)
Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? (2014) (64)
Modifiable risk factors predict functional decline among older women: a prospectively validated clinical prediction tool. The Study of Osteoporotic Fractures Research Group. (2000) (63)
Dentists as smoking cessation counselors. (1989) (62)
Treat-to-target for osteoporosis: is now the time? (2013) (62)
Comparing a Supine Radiologic Versus Standing Clinical Measurement of Kyphosis in Older Women: The Fracture Intervention Trial (2006) (62)
A randomized, controlled trial of the influence of prenatal parenting education on postpartum anxiety and marital adjustment. (1995) (62)
Goal‐directed treatment of osteoporosis (2013) (59)
Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates: A Meta-analysis. (2019) (58)
Vitamin D receptor gene polymorphisms and the risk of fractures in older women (1999) (58)
Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women (2007) (58)
Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes (2011) (57)
Quitting smoking (1992) (57)
Rapid Resting Heart Rate: A Simple and Powerful Predictor of Osteoporotic Fractures and Mortality in Older Women (2002) (56)
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid. (2014) (56)
Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. (2005) (56)
Fetuin-A and change in body composition in older persons. (2009) (55)
Successful Skeletal Aging: A Marker of Low Fracture Risk and Longevity. The Study of Osteoporotic Fractures (SOF) (2009) (55)
Informed Consent. (2017) (55)
Serum Insulin‐Like Growth Factor‐1 Binding Proteins 1 and 2 and Mortality in Older Adults: The Health, Aging, and Body Composition Study (2009) (55)
BONE MINERAL DENSITY AND RISK OF BREAST CANCER IN OLDER WOMEN : THE STUDY OF OSTEOPOROTIC FRACTURES (1997) (55)
Postmenopausal hormone therapy for prevention of fractures: how good is the evidence? (2001) (54)
The Ability of a Single BMD and Fracture History Assessment to Predict Fracture Over 25 Years in Postmenopausal Women: The Study of Osteoporotic Fractures (2018) (54)
Ethnicity and smoking: differences in white, black, Hispanic, and Asian medical patients who smoke. (1990) (54)
Use of alendronate and risk of incident atrial fibrillation in women (2008) (53)
Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study (2008) (53)
Hip Fractures Risk in Older Men and Women Associated With DXA‐Derived Measures of Thigh Subcutaneous Fat Thickness, Cross‐Sectional Muscle Area, and Muscle Density (2015) (53)
Women's views on chemoprevention of breast cancer: qualitative study. (2006) (52)
Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders (2018) (52)
Accuracy of mammographic breast density analysis: results of formal operator training. (2002) (52)
Risk Factors That Increase Risk of Estrogen Receptor–Positive and –Negative Breast Cancer (2017) (52)
Genome-wide association and functional studies identify a role for IGFBP3 in hip osteoarthritis (2014) (52)
Smoking counseling and preventive medicine. A survey of internists in private practices and a health maintenance organization. (1989) (51)
Quitting smoking: reasons for quitting and predictors of cessation among medical patients. (1992) (51)
PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites (2017) (51)
Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults (2009) (51)
Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group. (2000) (50)
Association of blood lead concentrations with mortality in older women: a prospective cohort study (2009) (50)
Indicators of "Healthy Aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survival (2010) (50)
Prediction of Clinical Non‐Spine Fractures in Older Black and White Men and Women With Volumetric BMD of the Spine and Areal BMD of the Hip: The Health, Aging, and Body Composition Study (2007) (50)
Risk Factors for Severity and Type of the Hip Fracture (2009) (49)
Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. (2011) (49)
Sex Hormones, Risk Factors, and Risk of Estrogen Receptor–Positive Breast Cancer in Older Women: A Long-term Prospective Study (2005) (49)
Prospective study of endogenous circulating estradiol and risk of stroke in older women. (2010) (49)
Sex steroid hormones, bone mineral density, and risk of breast cancer. (1997) (48)
Diabetes and Change in Bone Mineral Density at the Hip, Calcaneus, Spine, and Radius in Older Women (2013) (48)
Bone Density Loss Is Associated With Blood Cell Counts (2017) (48)
Dense and Nondense Mammographic Area and Risk of Breast Cancer by Age and Tumor Characteristics (2015) (48)
Staff involvement and special follow-up time increase physicians' counseling about smoking cessation: a controlled trial. (1991) (47)
Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial (2012) (47)
Mitochondrial DNA variation in human metabolic rate and energy expenditure. (2011) (47)
Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. (1995) (47)
Recommendations for the Clinical Evaluation of Agents for Treatment of Osteoporosis: Consensus of an Expert Panel Representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF) (2007) (47)
Genetic Variation in Candidate Osteoporosis Genes, Bone Mineral Density, and Fracture Risk: The Study of Osteoporotic Fractures (2008) (47)
Morphometric X-ray absorptiometry of the spine: Correlation in vivo with morphometric radiography (1994) (47)
Lasofoxifene and Cardiovascular Events in Postmenopausal Women With Osteoporosis: Five-Year Results From the Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) Trial (2010) (46)
Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. (2016) (46)
Identification of Novel Loci Associated With Hip Shape: A Meta‐Analysis of Genomewide Association Studies (2018) (46)
Change in hip bone mineral density and risk of subsequent fractures in older men (2012) (45)
Assessing the Impact of the COVID-19 Pandemic and Accompanying Mitigation Efforts on Older Adults (2020) (45)
Predictive value of FRAX for fracture in obese older women (2013) (45)
Effi cacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial (2009) (45)
Longitudinal change in energy expenditure and effects on energy requirements of the elderly (2013) (45)
Consequences of foot binding among older women in Beijing, China. (1997) (45)
Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers (2018) (44)
Clinical comparison of a novel breast DXA technique to mammographic density. (2006) (44)
Effects of antiresorptive treatment on nonvertebral fracture outcomes (2011) (44)
Training physicians about smoking cessation (1989) (44)
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women (2018) (44)
Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels. (2012) (44)
Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women. (2008) (44)
Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOS) Study. (2013) (44)
What PROOF proves about calcitonin and clinical trials. (2000) (44)
Suturing versus conservative management of lacerations of the hand: randomised controlled trial (2002) (43)
Family history and risk of osteoporotic fracture. Study of Osteoporotic Fractures Research Group. (1998) (43)
Activity energy expenditure and change in body composition in late life. (2009) (43)
Relationship of Blood Lead Levels to Incident Nonspine Fractures and Falls in Older Women: The Study of Osteoporotic Fractures (2008) (43)
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene (2012) (43)
Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2 (2016) (43)
Common genetic variants in ARNTL and NPAS2 and at chromosome 12p13 are associated with objectively measured sleep traits in the elderly. (2013) (43)
The FoxO3 gene and cause‐specific mortality (2016) (43)
Urinary Incontinence in Older Women: The Role of Body Composition and Muscle Strength: From the Health, Aging, and Body Composition Study (2017) (42)
The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. (2010) (42)
Prevention of hip fractures in older women: a population-based perspective. (1998) (42)
GWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortium (2016) (42)
Bone Mineral Density and Risk of Breast Cancer Differences by Family History of Breast Cancer (1998) (41)
Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. (1994) (41)
Chinese and U.S. internists adhere to different ethical standards (1999) (41)
Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures. (2008) (41)
Risk Factors for Nonvertebral Fracture in Obese Older Women (2011) (41)
Lipoprotein peroxidation and mobility limitation: results from the Health, Aging, and Body Composition Study. (2005) (41)
Large‐Scale Genome‐Wide Linkage Analysis for Loci Linked to BMD at Different Skeletal Sites in Extreme Selected Sibships (2006) (40)
Older Men With Anemia Have Increased Fracture Risk Independent of Bone Mineral Density (2017) (40)
Effect of Raloxifene on Urinary Incontinence: A Randomized Controlled Trial (2004) (40)
Endogenous Estrogen Levels and the Effects of Ultra‐Low‐Dose Transdermal Estradiol Therapy on Bone Turnover and BMD in Postmenopausal Women (2007) (40)
A Common Variant in the Telomerase RNA Component Is Associated with Short Telomere Length (2010) (39)
Height loss in older women: Risk of hip fracture and mortality independent of vertebral fractures (2012) (39)
Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? (1990) (39)
Estimates of the Proportion of Older White Men Who Would Be Recommended for Pharmacologic Treatment by the New US National Osteoporosis Foundation Guidelines (2010) (39)
Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. (2009) (38)
Conceiving the Research Question (2007) (38)
A 55-year-old woman with osteopenia. (2006) (37)
Daily Patterns of Accelerometer Activity Predict Changes in Sleep, Cognition, and Mortality in Older Men (2018) (37)
Genetic admixture, adipocytokines, and adiposity in Black Americans: the Health, Aging, and Body Composition study (2007) (37)
Evaluating the benefits and risks of postmenopausal hormone therapy. (1991) (36)
Activity energy expenditure and mobility limitation in older adults: differential associations by sex. (2009) (36)
Patient expectations and satisfaction with medical care for upper respiratory infections (1992) (36)
Muscle mass assessed by D3-Creatine dilution method and incident self-reported disability and mortality in a prospective observational study of community dwelling older men. (2020) (36)
Vertebral fracture in postmenopausal Chinese women: a population-based study (2017) (35)
Sex hormone levels and risk of breast cancer with estrogen plus progestin. (2013) (35)
Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. (2005) (35)
Association of estrogen receptor α polymorphisms with breast cancer risk in older Caucasian women (2005) (35)
Mitochondrial DNA sequence variation associated with dementia and cognitive function in the elderly. (2012) (35)
Visual Field Loss and Risk of Fractures in Older Women (2009) (34)
Osteoporosis : an evidence-based guide to prevention and management (2002) (34)
Trajectories of Lower Extremity Physical Performance: Effects on Fractures and Mortality in Older Women. (2016) (34)
The association of periodontal disease with kidney function decline: a longitudinal retrospective analysis of the MrOS dental study. (2016) (34)
Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density (2010) (34)
Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans (2014) (34)
Postmenopausal Bilateral Oophorectomy Is Not Associated With Increased Fracture Risk in Older Women (2004) (34)
Internists and nicotine gum. (1988) (33)
How drugs decrease fracture risk: lessons from trials. (2002) (33)
Association of change in muscle mass assessed by D3‐creatine dilution with changes in grip strength and walking speed (2019) (33)
Physical Performance and Radiographic and Clinical Vertebral Fractures in Older Men (2014) (33)
Combining quantitative and qualitative breast density measures to assess breast cancer risk (2017) (33)
The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) (2011) (33)
The index of radiographic area (IRA): a new approach to estimating the severity of vertebral deformity. (1991) (32)
Does Follow-up of Osteoporotic Women Treated with Antiresorptive Therapies Improve Effectiveness? (2002) (32)
Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension. (2020) (32)
Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans. (2016) (32)
Improved single muscle fiber quality in the oldest-old. (2016) (32)
Methods and reliability of radiographic vertebral fracture detection in older men: the osteoporotic fractures in men study. (2014) (32)
Associations of 25‐Hydroxyvitamin D and 1,25‐Dihydroxyvitamin D With Bone Mineral Density, Bone Mineral Density Change, and Incident Nonvertebral Fracture (2015) (31)
Meta-analysis of genome-wide association studies of HDL cholesterol response to statins (2016) (31)
Effect of Raloxifene on all-cause mortality. (2010) (31)
Association between endogenous hormones and sex hormone-binding globulin and bone turnover in older women: study of osteoporotic fractures. (2001) (31)
Long-term Cognitive Trajectories and Mortality in Older Women. (2016) (31)
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders. (2018) (30)
Risk factors for nonvertebral fracture in obese older women. (2011) (30)
PPAR-γ Pro12Ala genotype and risk of cognitive decline in elders (2008) (30)
Estrogen receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy in older women. (2008) (30)
LIFT study is discontinued (2006) (30)
Mitochondrial DNA m.3243A > G heteroplasmy affects multiple aging phenotypes and risk of mortality (2018) (30)
Vitamin D receptor gene polymorphisms and the risk of fractures in older women. For the Study of Osteoporotic Fractures Research Group. (1999) (29)
Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. (2008) (29)
Areal and volumetric bone mineral density and risk of multiple types of fracture in older men. (2016) (29)
Genetic variants in RBFOX3 are associated with sleep latency (2016) (29)
Disentangling the genetics of lean mass. (2019) (28)
Vitamin D Supplementation and Increased Risk of Falling: A Cautionary Tale of Vitamin Supplements Retold. (2016) (28)
High hip fracture risk in men with severe aortic calcification: MrOS study (2014) (28)
Once‐yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial (2011) (28)
Endometrial Effects of Tibolone in Elderly, Osteoporotic Women (2008) (28)
Longevity-Associated FOXO3 Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations (2016) (28)
Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. (2013) (28)
Cystatin C and risk of hip fractures in older women (2013) (28)
Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women (2007) (28)
Dysmobility Syndrome Independently Increases Fracture Risk in the Osteoporotic Fractures in Men (MrOS) Prospective Cohort Study (2018) (27)
Aspirin and nonsteroidal antiinflammatory drug use in elderly women: effects on a marker of bone resorption. The Study of Osteoporotic Fractures Research Group. (1997) (27)
2 Conceiving The Research Question (2008) (27)
The predictive value of physical examinations for ascites. (1985) (27)
Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors (2007) (27)
Postmenopausal hormones and sleep quality in the elderly: a population based study (2010) (26)
F2‐Isoprostanes and Adiposity in Older Adults (2011) (26)
Stop (mis)classifying fractures as high- or low-trauma or as fragility fractures (2020) (26)
Association between serum fructosamine and mortality in elderly women: the study of osteoporotic fractures. (1999) (26)
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. (2012) (26)
Effect of Combination Folic Acid, Vitamin B6, and Vitamin B12 Supplementation on Fracture Risk in Women: A Randomized, Controlled Trial (2017) (26)
Comprar Designing Clinical Research | Steven R. Cummings | 9781608318049 | Lippincott Williams & Wilkins (2013) (25)
S-9. Raloxifene Reduces the Risk of Incident Vertebral Fractures: 24-Month Interim Analyses (1998) (25)
Meta‐Analysis of Genomewide Association Studies Reveals Genetic Variants for Hip Bone Geometry (2019) (25)
Indicators of Lifetime Estrogen Exposure: Effect on Breast Cancer Incidence and Interaction With Raloxifene Therapy in the Multiple Outcomes of Raloxifene Evaluation Study Participants (2001) (25)
The complex genetics of gait speed: genome-wide meta-analysis approach (2017) (25)
Does a History of Non-Vertebral Fracture Identify Women Without Osteoporosis for Treatment? (2008) (24)
Abdominal aortic calcification and risk of fracture among older women - The SOF study. (2015) (24)
The potential value of monitoring bone turnover markers among women on alendronate (2012) (24)
Fetuin‐A and BMD in Older Persons: The Health Aging and Body Composition (Health ABC) Study (2009) (24)
Association of the VDR Translation Start Site Polymorphism and Fracture Risk in Older Women (2007) (24)
Association of Incident, Clinically Undiagnosed Radiographic Vertebral Fractures With Follow‐Up Back Pain Symptoms in Older Men: the Osteoporotic Fractures in Men (MrOS) Study (2017) (24)
Age, body mass, usage of exogenous estrogen, and lifestyle factors in relation to circulating sex hormone-binding globulin concentrations in postmenopausal women. (2014) (23)
Vertebral Fractures and Mortality in Older Women (2017) (23)
Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX. (2016) (23)
Dietary ratio of animal to vegetable protein and rate of bone loss and risk of fracture in postmenopausal women. (2001) (23)
Osteoporosis clinical trials endpoints: candidate variables and clinimetric properties. (1997) (23)
Hip axis length and osteoporotic fractures. Study of Osteoporotic Fractures Research Group. (1995) (23)
Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals. (2019) (22)
Prediction models of prevalent radiographic vertebral fractures among older women. (2014) (22)
Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study (2017) (22)
The association of cataract with leukocyte telomere length in older adults: defining a new marker of aging. (2011) (22)
Risk and Prevention of Fracture in Patients With Major Medical Illnesses: A Mini‐Review (2016) (22)
History of alendronate. (2020) (22)
Association of total adiposity and computed tomographic measures of regional adiposity with incident cancer risk: a prospective population-based study of older adults. (2014) (22)
Weight Trajectory over 20 Years and Likelihood of Mild Cognitive Impairment or Dementia Among Older Women (2017) (21)
Home-Based Trials in Adolescent Migraine: A Randomized Clinical Trial (2017) (21)
Relationship Between Pretreatment Rate of Bone Loss and Bone Density Response to Once‐Yearly ZOL: HORIZON‐PFT Extension Study (2015) (21)
1,25-Dihydroxyvitamin D 3 and Muscle Strength in the Elderly: A Randomized Controlled Trial* (1991) (21)
Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) study. (2010) (21)
Mitochondrial DNA Heteroplasmy Associations With Neurosensory and Mobility Function in Elderly Adults. (2015) (20)
Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones (2017) (20)
Usual physical activity and hip fracture in older men: an application of semiparametric methods to observational data. (2011) (20)
Counseling medical patients about cigarette smoking: a comparison of the impact of training on nurse practitioners and physicians. (1990) (19)
PPAR-gamma Pro12Ala genotype and risk of cognitive decline in elders. (2008) (19)
Calciotropic hormones and the risk of hip and nonspine fractures in older adults: The health ABC study (2012) (19)
Physical activity and longevity of college alumni. (1986) (19)
Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium (2015) (19)
Association of endothelial nitric oxide synthase genotypes with bone mineral density, bone loss, hip structure, and risk of fracture in older women: the SOF study. (2006) (19)
Arterialized venous bicarbonate is associated with lower bone mineral density and an increased rate of bone loss in older men and women. (2015) (19)
The Importance of Muscle Versus Fat Mass in Sarcopenic Obesity: A Re-evaluation Using D3-Creatine Muscle Mass Versus DXA Lean Mass Measurements. (2020) (19)
Bone Density Screening: A New Level of Evidence? (2005) (19)
Estrogen Metabolizing Polymorphisms and Breast Cancer Risk Among Older White Women (2005) (19)
Bone mass and bone loss in the elderly: a special case? (1993) (18)
High‐throughput serum proteomics for the identification of protein biomarkers of mortality in older men (2018) (18)
Data mining identifies Digit Symbol Substitution Test score and serum cystatin C as dominant predictors of mortality in older men and women. (2012) (18)
Estimating probability of non‐response to treatment using mixture distributions (2001) (18)
Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis. (2020) (18)
Prospective study of endogenous circulating estradiol and risk of stroke in older women (2010) (18)
Sclerostin and bone strength in women in their 10th decade of life (2013) (18)
Novel methods to evaluate fracture risk models (2011) (18)
Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight (2012) (18)
Getting Started : The Anatomy and Physiology of Clinical Research (2007) (17)
Mean nocturnal respiratory rate predicts cardiovascular and all-cause mortality in community-dwelling older men and women (2019) (17)
Molecular damage in aging (2021) (17)
Study of Tomography Of Nephrolithiasis Evaluation (STONE): methodology, approach and rationale. (2014) (16)
The Women's Health Initiative randomized trial of calcium plus vitamin D: Effects on breast cancer and arthralgias. (2006) (16)
Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention (2017) (16)
Prevention of osteoporosis and osteoporotic fractures. (1985) (16)
Prediction models of prevalent radiographic vertebral fractures among older men. (2014) (16)
A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium (2016) (16)
Relationship of Bisphosphonate Therapy and Atrial Fibrillation/Flutter: Outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study. (2016) (16)
Changes in Biochemical Markers of Bone Turnover in Women Treated with Raloxifene: Influence of Regression to the Mean (2001) (16)
A randomized controlled trial of a Chinese herbal remedy to increase energy, memory, sexual function, and quality of life in elderly adults in Beijing, China. (2003) (16)
A Pooled Analysis of Fall Incidence From Placebo‐Controlled Trials of Denosumab (2020) (15)
Walking Speed and Muscle Mass Estimated by the D3-Creatine Dilution Method Are Important Components of Sarcopenia Associated With Incident Mobility Disability in Older Men: A Classification and Regression Tree Analysis. (2020) (15)
Baseline serum estradiol and fracture reduction during treatment with hormone therapy: The Women's Health Initiative randomized trial (2009) (15)
Estimating long‐term effects of treatment from placebo‐controlled trials with an extension period, using virtual twins (2010) (15)
Bone-muscle indices as risk factors for fractures in men: the Osteoporotic Fractures in Men (MrOS) Study. (2014) (15)
S03 Alendronate prevents vertebral and clinical fractures in women with existing vertebral fractures: Results of the fracture intervention trial (1996) (15)
Neurotransmitter Pathway Genes in Cognitive Decline During Aging: Evidence for GNG4 and KCNQ2 Genes (2018) (15)
Epidemiologic studies of osteoporotic fractures: Methodologic issues (2007) (15)
Rest-activity patterns and falls and fractures in older men (2017) (14)
Research Using Existing Data (14)
Bone mass, rates of osteoporotic fractures, and prevention of fractures: are there differences between China and Western countries? (1994) (14)
Genetic variation in two bone‐related proteins: Is there an association with bone mineral density or skeletal size in postmenopausal women? (1992) (14)
Association of nitrate use with risk of new radiographic features of hip osteoarthritis in elderly white women: the study of osteoporotic fractures. (2003) (14)
The Fracture Intervention Trial (1997) (14)
Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans (2017) (14)
Bone Loss at the Hip and Subsequent Mortality in Older Men: The Osteoporotic Fractures in Men (MrOS) Study (2017) (14)
Influence of smoking on the antiosteoporotic efficacy of raloxifene. (2001) (14)
Self‐reported weight at birth predicts measures of femoral size but not volumetric BMD in eldery men: MrOS (2011) (14)
Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension. (2011) (13)
Prevention of osteoporotic hip fracture: global versus high-risk strategies. (1998) (13)
Bone mineral density and risk of breast cancer: differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group. (1998) (13)
Modeling the shape and composition of the human body using dual energy X-ray absorptiometry images (2017) (13)
Zoledronate. (2020) (13)
Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes (2017) (13)
Red Cell Distribution Width Is a Risk Factor for Hip Fracture in Elderly Men Without Anemia (2019) (13)
Is tubal ligation a risk factor for low bone density and increased risk of fracture? (1995) (13)
Large-scale pharmacogenomic study of sulfonylureas and the QT, JT, and QRS intervals: CHARGE Pharmacogenomics Working Group (2016) (13)
Clinical Trials Without Clinical Sites. (2021) (13)
The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747] (2006) (12)
Mitochondrial DNA sequence variation is associated with free-living activity energy expenditure in the elderly. (2012) (12)
A New Framework for Describing and Quantifying the Gap Between Proof and Practice (2003) (12)
High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures: The MrOS Sweden Study (2018) (12)
Vertebral fractures associated with osteoporosis : Patient management. Discussion (1997) (12)
VITAL Findings - A Decisive Verdict on Vitamin D Supplementation. (2022) (12)
Can Classification and Regression Tree Analysis Help Identify Clinically Meaningful Risk Groups for Hip Fracture Prediction in Older American Men (The MrOS Cohort Study)? (2019) (12)
The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism: A systematic review and meta-analysis. (2019) (12)
Accelerating the Search for Interventions Aimed at Expanding the Health Span in Humans: The Role of Epidemiology. (2019) (12)
Hip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group. (1999) (12)
Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial (2020) (12)
signatureSearch: environment for gene expression signature searching and functional interpretation (2020) (12)
Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy (1995) (11)
The Paradox of Small Changes in Bone Density and Reductions in Risk of Fracture with Raloxifene (2001) (11)
Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer (2019) (11)
Familial aggregation of bone mineral density and bone mineral content in a Chinese population (2005) (11)
Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review (2020) (11)
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics (2018) (10)
Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis (2007) (10)
Serum fructosamine level and the risk of hip fracture in elderly women: a case-cohort study within the study of osteoporotic fractures. (1998) (10)
Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults (2015) (10)
Decision Analysis Approaches in Solitary Pulmonary Nodules (1989) (10)
Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial. (2004) (10)
The risk of fracture following hospitalization in older women and men. (2008) (10)
Bone density for prediction of hip fracture (1993) (10)
The Study of Osteoporotic Fractures: Major Findings and Contributions (2008) (10)
[Optimal management of patients with stress fractures and the role of the orthopedic surgeon in reducing the risk of new fractures]. (2006) (9)
Filtering FRAX® (2009) (9)
Erratum: Fracture risk reduction with alendronate in women with osteoporosis: The fracture intervention trial (Journal of Clinical Endocrinology and Metabolism, 85 (4118-4124)) (2001) (9)
Association Between Muscle Mass Determined by D3‐Creatine Dilution and Incident Fractures in a Prospective Cohort Study of Older Men (2022) (9)
Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity (2021) (9)
Bone Mineral Density and Age‐Related Maculopathy in Older Women (2007) (9)
Long‐Term Weight Trajectory and Risk of Hip Fracture, Falls, Impaired Physical Function, and Death (2018) (9)
Association of mammographic density measures and breast cancer “intrinsic” molecular subtypes (2021) (9)
Determinants of Change in Objectively Assessed Sleep Duration Among Older Men (2017) (9)
Sonographic detection of ascites in liver disease. (1984) (9)
Deep Learning With Electronic Health Records for Short-Term Fracture Risk Identification: Crystal Bone Algorithm Development and Validation (2020) (9)
Ten years of Denosumab (DMAB) treatment in postmenopausal women with osteoporosis. Results from the FREEDOM Extension trial. (2016) (8)
Women's views on chemoprevention of breast cancer (2006) (8)
Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden (2013) (8)
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan (2022) (8)
The effects of denosumab on bone mineral density (BMD) and fracture by level of renal function (2010) (8)
Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis. (2012) (8)
Association between variation in red cell size and multiple aging-related outcomes. (2020) (8)
Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2017) (8)
Crystal Bone: Predicting Short-Term Fracture Risk From Electronic Health Records With Deep Learning. (2020) (7)
Pharmacogenomics Study of Thiazide Diuretics and QT Interval in Multi-Ethnic Populations: The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) (2017) (7)
What cut-point in gait speed best discriminates community dwelling older adults with mobility complaints from those without? A pooled analysis from the Sarcopenia Definitions and Outcomes Consortium. (2021) (7)
Discovering patterns of pleiotropy in genome-wide association studies (2018) (7)
Meta-analysis identifies mitochondrial DNA sequence variants associated with walking speed (2018) (7)
Does rosiglitazone adversely affect bone formation and bone mineral density in postmenopausal women? (2007) (7)
Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women. (2009) (7)
Mitochondrial DNA Sequence Variation Associated With Peripheral Nerve Function in the Elderly. (2015) (7)
Spinal radiographs in those with back pain—when are they appropriate to diagnose vertebral fractures? (2017) (7)
Primary prevention of breast cancer: new approaches. (2007) (7)
Individual periodic limb movements with arousal are temporally associated with nonsustained ventricular tachycardia: a case-crossover analysis. (2019) (6)
Notice of Retraction: Jamal SA, et al. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial. JAMA. 2011;305(8):800-807. (2016) (6)
Individual and joint trajectories of change in bone, lean mass and physical performance in older men (2020) (6)
A single, annual, high dose of oral vitamin D increased falls and fractures in older women (2010) (6)
Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment: Results of the Continuing Outcomes Relevant to Evista (CORE) trial. (2004) (6)
Postmenopausal Hormone Therapy and Age-Related Maculopathy in Older Women (2008) (6)
Factor analysis to determine relative contributions of strength, physical performance, body composition and muscle mass to disability and mobility disability outcomes in older men (2022) (6)
THE FRACTURE INTERVENTION TRIAL. AUTHORS' REPLY (1997) (6)
Osteoporosis and prevention of fractures: practical approaches for orthopaedic surgeons. (2002) (5)
Mitochondrial DNA variants and pulmonary function in older persons (2019) (5)
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism (2021) (5)
Serum estradiol level and risk of breast cancer during treatment with raloxifene (2002) (5)
Pharmacologic treatment to prevent fractures: from markers to patients (2009) (5)
Poster 150: Effect of Once-Yearly Infusion of 5mg of Zoledronic Acid in Postmenopausal Women With Osteoporosis: The HORIZON-Pivotal Fracture Trial (2007) (5)
CT muscle density, D3Cr muscle mass and body fat associations with physical performance, mobility outcomes and mortality risk in older men. (2021) (5)
A History of Pivotal Advances in Clinical Research into Bone and Mineral Diseases (2018) (5)
Proteomic assessment of serum biomarkers of longevity in older men (2020) (5)
High body mass index, adjusted for BMD, is a risk factor for fracture in women (2012) (5)
Epidemiology and outcomes of osteoporotic fractures. Commentary (2002) (5)
Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial (2016) (5)
Bone density regression to the mean and the individual patient. (2001) (5)
Safety observations from denosumab long-term extension and cross-over studies in postmenopausal women with osteoporosis (2011) (5)
Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses (2022) (5)
Guest Editorial: How Long Should Patients with Osteoporosis Be Treated with Bisphosphonates? (2000) (4)
The U.S. national osteoporosis foundation (NOF) guidelines: Recommendations for pharmacologic treatment (2008) (4)
Adult atopic eczema and the risk of dementia: A population-based cohort study. (2022) (4)
5. An International Multicenter Randomized Comparison of Balloon Kyphoplasty and Non-Surgical Management in Patients with Acute Vertebral Body Compression Fractures (2007) (4)
Alendronate and fracture prevention. (1999) (4)
Associations between biomarkers of cellular senescence and physical function in humans: observations from the lifestyle interventions for elders (LIFE) study (2022) (4)
Effect of denosumab on fracture healing in postmenopausal women with osteoporosis: Results from the FREEDOM trial (study sponsored by Amgen Inc.) (2010) (4)
Associations of Smoking, Moderate Alcohol Use, and Function: A 20-Year Cohort Study of Older Women (2018) (4)
PD4-03 A RANDOMIZED TRIAL OF ULTRASOUND VERSUS COMPUTED TOMOGRAPHY FOR IMAGING PATIENTS WITH SUSPECTED NEPHROLITHIASIS (2014) (4)
A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Care for Acute Vertebral Compression Fracture (2009) (4)
Mitochondrial DNA m.13514G>A heteroplasmy is associated with depressive symptoms in the elderly (2018) (4)
Calcium intake and fracture risk (1997) (4)
THE ASSOCIATION BETWEEN D3CR MUSCLE MASS AND MORTALITY IN COMMUNITY-DWELLING OLDER MEN (2019) (4)
Comparison of Subregional Breast Density with Whole Breast Density (2010) (4)
Higher red cell distribution width and poorer hospitalization‐related outcomes in elderly patients (2022) (3)
Effects of arzoxifene on fracture incidence in postmenopausal women with osteoporosis or with low bone mass (2010) (3)
FREEDOM TRIAL: DENOSUMAB IS NOT ASSOCIATED WITH FRACTURE HEALING COMPLICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS (2011) (3)
A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates (2016) (3)
Calcium plus vitamin D supplementation and the risk of fractures: Commentary (2006) (3)
Review: parathyroid hormone increases lumbar spine bone mineral density and decreases vertebral fractures in osteoporosis. (2003) (3)
Recent fall and high imminent risk of fracture in older men and women. (2022) (3)
Research priorities for measuring biologic age: summary and future directions from the Research Centers Collaborative Network Workshop (2022) (3)
Effects of continuing or stopping alendronate after 5 years of treatment. The fracture intervention trial long-term extension (FLEX): A randomized trial - Commentary (2007) (3)
Effects of Arzoxifene on Breast Cancer Incidence in Postmenopausal Women with Osteoporosis or with Low Bone Mass. (2009) (3)
Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial (2013) (3)
The response of bone turnover markers to lasofoxifene: The PEARL trial (2009) (3)
11 Prevention of osteoporotic fractures: What we need to know (1991) (3)
RESPONSE: Re: Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene (2005) (3)
The Effects of Tibolone in Older Postmenopausal Women (2008) (3)
Correction: The complex genetics of gait speed: Genome-wide metaanalysis approach [Aging, (Albany NY), 9, 1, (2017), (209-246)]doi 10.18632/aging.101151 (2017) (3)
EPIDEMIOLOGY OF FALLS AMONG 11009 ELDERLY MEN - THE MR OS STUDY (2010) (3)
Skeletal aging: from bench to bed side. (2013) (3)
High mammographic density in women of Ashkenazi Jewish descent (2013) (3)
Urinary Incontinence and Nocturia in Older Men: Associations with Body Mass, Composition, and Strength in the Health, Aging, and Body Composition Study. (2019) (3)
MITOCHONDRIAL DNA HETEROPLASMY LEADS TO AGE-RELATED FUNCTIONAL DECLINE AND INCREASED MORTALITY RISK (2017) (3)
CLINICAL REVIEW 140 Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials (2002) (3)
Finite Element Analysis of Proximal Femur QCT Scans for the Assessment of Hip Fracture Risk In Older Men (2008) (3)
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON‐Pivotal Fracture Trial (PFT) (2012) (2)
Long-term denosumab treatment of postmenopausal women with osteoporosis: results from the first year extension study of the FREEDOM trial (2010) (2)
SAT0342 Treatment of postmenopausal women with osteoporosis for six years with denosumab: Three-year results from the freedom extension (2013) (2)
Percentage of women achieving non-osteoporotic BMD T-scores at the spine and hip over 8 years of denosumab treatment (2014) (2)
Response to BONE-D-14-00884. (2015) (2)
The Adverse Effects and Safety of Bisphosphonates (2010) (2)
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age (2022) (2)
92190999 Results of bone densitometry affect women's decisions about taking measures to prevent fractures (1992) (2)
92172829 The accuracy of self-report of fractures in elderly women: Evidence from a prospective study (1992) (2)
Use of fracture history to predict long term risk of specific fracture types: Is any non-vertebral fracture history an adequate predictor? (2009) (2)
IDENTIFICATION OF ADAMTS7 AND CEACAM19 AS CANDIDATE HEALTHY AGING ASSOCIATED GENES (2019) (2)
Clonal Hematopoiesis Analyses in Clinical, Epidemiologic, and Genetic Aging Studies to Unravel Underlying Mechanisms of Age-Related Dysfunction in Humans (2022) (2)
SUN-622 The Risk of Hip and Non-Vertebral Fractures in Diabetes: A Systematic Review and Meta-Analysis Update (2020) (2)
Nulliparity and Osteoporotic Fracture Risk (2003) (2)
The metabolic syndrome is associated with elevated circulating oxidized LDL in the health, aging and body composition cohort (2002) (2)
Glycated Peptide Levels Are Associated With Cognitive Decline Among Nondiabetic Older Women (2019) (2)
Abstract OT3-02-01: Development of cell-free nucleic acid-based tests for early detection of breast cancer: The STRIVE study (2018) (2)
Alendronate, Osteoporocis, and Atherosclerosis. Authors' reply (2008) (2)
Do cardiologists and general internists differ in testing and treating patients with aortic stenosis or mitral regurgitation? A preliminary study with editorial perspective. (1999) (2)
AN INTERNATIONAL MULTICENTRE RANDOMISED COMPARISON OF BALLOON KYPHOPLASTY AND NONSURGICAL CARE IN PATIENTS WITH ACUTE VERTEBRAL BODY COMPRESSION FRACTURES (2012) (2)
Rapid prediction of in-hospital mortality among adults with COVID-19 disease (2022) (2)
Publisher Correction: A meta-analysis of genome-wide association studies identifies multiple longevity genes (2021) (2)
Review: calcium supplementation has a small positive effect on bone mineral density but not fractures in postmenopausal women (2004) (2)
AFTER 3 YEARS OF ANNUAL ZOLEDRONIC ACID, WHO SHOULD REMAIN ON TREATMENT? RESULTS FROM THE HORIZON-PFT EXTENSION STUDY (2012) (1)
Bruce Ettinger, MD (2020) (1)
The risk and prevention of hip fractures (1984) (1)
ASBMR 26th Annual Meeting 1001–1222 (2011) (1)
Prevention of osteoporotic fractures: what we need to know. (1991) (1)
Use of Alendronate After 5 Years of Treatment—Reply (2007) (1)
Risk factors for fractures (2006) (1)
Daily nitroglycerin increases bone formation, bone mass, bone structure, and indices of bone strength: A two-year randomized trial (2011) (1)
A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Care for Acute Vertebral Fracture: Who Responds Best? (2008) (1)
Genome-Wide Meta-analysis of Variant-by-Diuretic Interactions as Modulators of Lipid Traits in Persons of European and African Ancestry (2019) (1)
Abstract IA22: Mammographic density: A risk factor for all breast cancers or only specific subtypes? (2016) (1)
Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density (2021) (1)
Bone Mineral Density and High-Trauma Fractures—Reply (2008) (1)
The Effect of Denosumab on Bone Turnover Markers (BTM) in Postmenopausal Women With Osteoporosis (2010) (1)
What accounts for an inadequate response to zoledronic acid (2010) (1)
Abstract 9793: Pcsk9 Loss-of-function Variants, Low-density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From the REGARDS Study and CHARGE Consortium (2015) (1)
Walking Speed and Muscle Mass Estimated by the D 3 -Creatine Dilution Method Are Important Components of Sarcopenia Associated With Incident Mobility Disability in Older Men: A Classification and Regression Tree Analysis Fractures in Men (MrOS) Study Group (2021) (1)
Managing Solitary Pulmonary Nodules (2015) (1)
Genome-Wide Association Analysis of the Sense of Smell in US Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans (1)
95044464 Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women (1995) (1)
Training Physicians in Counseling about Smoking Cessation (2020) (1)
S12 Five year results of a randomised placebo controlled trial of lasofoxifene (PEARL) on the incidence of ER positive breast cancer in postmenopausal women with osteoporosis (2009) (1)
0033 Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women by baseline estradiol levels (2009) (1)
OP16Effect of denosumab on bone turnover markers in postmenopausal osteoporosis: Initial response and subsequent release from suppression (2009) (1)
A randomized double-blind study of denosumab compared with zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonate. (2015) (1)
How long should patients with osteoporosis be treated with bisphosphanates? (2000) (1)
In postmenopausal women with higher fracture risk, denosumab reduced the incidence of hip and new vertebral fractures: A FREEDOM study subanalysis (2011) (1)
Hip fracture. (1996) (1)
Prevention of hip fractures : Risk factor modification. Discussion (1997) (1)
Fracture risk factors during treatment with denosumab (2013) (1)
High mammographic density in women of Ashkenazi Jewish descent (2013) (1)
EFFECT OF 6-YEAR TREATMENT OF OSTEOPOROSIS WITH ZOLEDRONIC ACID 5MG (ACLASTA) COMPARED WITH THE 3-YEAR-TREATMENT, RESULTS OF EXTENDED HORIZON PFT STUDY (2012) (1)
Melatonin for Adolescent Migraine Prevention: A Pilot Internet-based Randomized Controlled Trial (P2.163) (2017) (1)
Correction: The complex genetics of gait speed: genome-wide meta-analysis approach (2017) (1)
19th annual meeting of the International Urogynecological Association (2004) (1)
Analysis of Health Benefits and Cost-Effectiveness of Mammography for Breast Cancer (2011) (1)
Denosumab treatment for 6 years in postmenopausal women with osteoporosis: The first 3 years of the freedom extension (2012) (1)
Mitochondrial energetics in skeletal muscle are associated with leg power and cardiorespiratory fitness in the Study of Muscle, Mobility, and Aging (SOMMA). (2022) (1)
Complementary and Integrated Studies of Longevity and Healthy Aging (2020) (0)
200 Variation in skin barrier function among older adults in a large cohort of healthy aging (2020) (0)
Effect of denosumab on the incidence of nonvertebral fractures in postmenopausal women at increased risk of fracture: A freedom study subanalysis (study sponsored by Amgen Inc) (2010) (0)
Successfully publishing articles on clinical research (2008) (0)
Books Received (2002) (0)
Folate plus vitamin B12 reduced hip fractures in patients with poststroke hemiplegia. (2005) (0)
Body composition and hip fracture risk in older women: A prospective study (2006) (0)
EffectofNitroglycerinOintmentonBoneDensity and Strength in Postmenopausal Women (2016) (0)
Parathyroid hormone decreased fracture rates and increased bone mineral density in postmenopausal women (2001) (0)
Rates of fracture after stroke in international population-based cohorts. (2005) (0)
Running title: Mammographic Density Phenotypes & Breast Cancer (2015) (0)
List of Reviewers 2002–2003 (2003) (0)
Authors‘ Response: Low Vitamin B12 and Bone Loss: A Role for Folate Deficiency (2004) (0)
Sex Hormone Exposure and Age–Related Maculopathy in Elderly Women (2005) (0)
Deep learning-based algorithms to detect vertebral fractures and osteoporosis using lateral spine X-ray radiograph (2022) (0)
Lipoprotein peroxidation and onset of mobility disability - Results from the health ABC study (2005) (0)
A randomized trial (2011) (0)
Functional impact of first and recurrent vertebral fracture: A prospective study (2006) (0)
Corrigendum to: CT Muscle Density, D3Cr Muscle Mass, and Body Fat Associations With Physical Performance, Mobility Outcomes, and Mortality Risk in Older Men. (2021) (0)
Extended safety observations from denosumab administration in postmenopausal women from FREEDOM and FREEDOM extension trials (2011) (0)
THE ROLE OF BODY COMPOSITION AND STRENGTH ON URINARY INCONTINENCE IN WOMEN FROM THE HEALTH ABC STUDY (2017) (0)
Abstract B18: Personalizing the frequency of mammography: Cost effectiveness of screening mammography for women age 40 to 80 by breast density and other risk factors (2010) (0)
Postmenopausal hormone therapy and mortality. (1997) (0)
Summary--curing osteoporosis. (2004) (0)
Future management of osteoporosis (2009) (0)
Relationship between change in total hip BMD in response to zoledronic acid 5 mg and pre-treatment change in total hip BMD: The HORIZON-PFT Extension study (2012) (0)
Biomarkers of cellular senescence in idiopathic pulmonary fibrosis (2023) (0)
Response to letter of Meinert et al (2008) (0)
Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. (2016) (0)
Incidence and Cost of Clinically Recognized Vertebral Fracture in China (2022) (0)
The long-term safety and efficacy of zoledronic acid in the treatment of osteoporosis: a 3-year, randomized extension to the HORIZON-pivotal fracture trial (PFT) (2011) (0)
Author response for "Bruce Ettinger, MD IN MEMORIAM" (2020) (0)
PAPER 195: A RANDOMIZED TRIAL OF BALLOON KYPHOPLASTY AND NONSURGICAL CARE FOR PATIENTS WITH ACUTE VERTEBRAL COMPRESSION FRACTURES (2010) (0)
P4-130: Telomere length and cognitive function in community-dwelling elders: Findings from the Health Aging and Body Composition (Health ABC) Study (2008) (0)
91235233 Non-trauma mortality in elderly women with low bone mineral density (1992) (0)
The genetic basis of cross-phenotype correlation with bone fracture risk: the GEFOS consortium (2013) (0)
Summary of session II and concluding remarks (1997) (0)
The percentage reduction in vertebral fracture risk with lasofoxifene explained by change in spine bone mineral density (2010) (0)
A RANDOMIZED TRIAL OF BALLOON KYPHOPLASTY AND NONSURGICAL CARE FOR PATIENTS WITH ACUTE VERTEBRAL COMPRESSION FRACTURES (2008) (0)
Freedom Trial First-Year Extension: Results from 4 Years of Denosumab Exposure in Women with Postmenopausal Osteoporosis (2010) (0)
Comment on: continuing outcomes relevant to evista : Breast cancer incidence in post menopausal osteoporotic women in a randomized trial of raloxifene. Authors' reply (2005) (0)
Abstract P5-09-05: A model with polygenic risk score and mammographic density predicts interval cancers (2017) (0)
Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men Epidemiology (2009) (0)
Cross-sectional and prospective association between oxidized LDL, adiposity and type 2 diabetes (2007) (0)
Bone Mineral Density and High-Trauma Fractures. Authors' reply (2008) (0)
Smoking, Alcohol, and Neuromuscular Function in Older Women-Reply (1995) (0)
INTEGRATED LONG-TERM BONE MINERAL DENSITY (BMD) OUTCOMES IN WOMEN RECEIVING RELUGOLIX COMBINATION THERAPY IN LIBERTY AND SPIRIT STUDIES VS NON-TREATED WOMEN (2021) (0)
Osteoporose-Update 1/2007 (2007) (0)
An Investigation of Selected Candidate Genes for Five-Year Incidence of Age-Related Maculopathy (ARM)in Older Women (2008) (0)
In Reply. (2017) (0)
729 EXERCISE, BONE MASS, AND OSTEOPOROSIS (1990) (0)
Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry (2019) (0)
Response to “Red Cell Distribution Width Is a Risk Factor for Hip Fracture in Elderly Men Without Anemia” (2021) (0)
Alendronate and Fracture Prevention—Reply (1999) (0)
Bone mineral density predicts the risk of breast cancer in older women. The study of osteoporotic fractures (2006) (0)
Mammographic density and risk of breast cancer by age and tumor characteristics (2013) (0)
Deep learning predicts all-cause mortality from longitudinal total-body DXA imaging (2022) (0)
Identifying Translational Longevity Targets With Genetically Mediated Transcriptome-Wide Association Studies (2020) (0)
Percentage of women achieving non-osteoporotic BMD T-scores at the lumbar spine (LS) and total hip (TH) during up to 8 years of Denosumab (Dmab) treatment (2015) (0)
Running title: Dense breast volume and risk (2011) (0)
Abstract 19547: FOXO3 Genotype Strongly Impacts Coronary Heart Disease Mortality in Three Populations (2015) (0)
Effect of Denosumab on the Incidence of Hip and New Vertebral Fractures in Postmenopausal Women With High Fracture Risk: A Subanalysis of the FREEDOM Study (2010) (0)
Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer (2019) (0)
The biology of aging: Implications for osteoporosis (2010) (0)
Single Muscle Fiber Characteristics of The Oldest-Old: 3190 Board #1 May 30, 9 (2015) (0)
An Online Risk Calculator for Rapid Prediction of In-hospital Mortality from COVID-19 Infection (2021) (0)
Authors’ response to KD Stathopoulos regarding “Stop (Mis)classifying Fractures as High or Low Trauma or as Fragility Fractures” (2021) (0)
SERMS and tibolone: Recent advances (2008) (0)
Correction to: Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study (2017) (0)
RELATIONSHIP OF BISPHOSPHONATE THERAPY AND ATRIAL FIBRILLATION/ATRIAL FLUTTER: THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY (2011) (0)
Corrigendum (1995) (0)
The effect of alendronate on rates of vertebral and non-vertebral fractures in women with vertebral fractures: Preliminary results of the fracture intervention trial (2006) (0)
Baseline Endogenous Estradiol and the Association of Hormone Therapy with Breast Cancer Risk, the Women's Health Initiative Clinical Trials. (2009) (0)
I88. Biology of Ageing Applied to Bone and Muscle (2015) (0)
Abstract B99: Hot flashes, hormone therapy, and breast cancer risk: The Women's Health Initiative Clinical Trials (2010) (0)
Renal Function and Bisphosphonate Safety (2007) (0)
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals (2021) (0)
Remembering Dr Arnold J Kahn: June 18, 1936–June 16, 2021 (2022) (0)
OR13-07 Crystal Bone: Personalized, Short-Term Fracture Risk Prediction with Natural Language Processing Methods (2020) (0)
Abstract B27: Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes (2017) (0)
Prediction of In-hospital Mortality among Adults with COVID-19 Infection (2021) (0)
Abstract P2-10-05: A breast cancer multi-racial/ethnic polygenic risk score for improved personalized breast cancer screening (2020) (0)
THE LONGEVITY CONSORTIUM VISION (2019) (0)
Association between frizzled related protein polymorphisms and osteoporosis phenotypes in older women (2003) (0)
BONE DENSITY FOR PREDICTION OF HIP FRACTURE. AUTHOR'S REPLY (1993) (0)
Osteoporosis : Trials and tribulations. Discussion (1997) (0)
MYOSTATIN IN OLDER ADULTS: THE HEALTH, AGING, AND BODY COMPOSITION (HEALTH ABC) STUDY (2017) (0)
Sex Hormones and Risk of Estrogen Receptor (ER)-Positive and ER-Negative Breast Cancer. (2009) (0)
Incident Urinary Incontinence in Older Men: Prospective Associations with Adiposity and Strength Measures in a Multicenter, Biracial Cohort (2019) (0)
???Physician Denigration??? Questioned in Smoking-Cessation Article (1990) (0)
Goals of treatment for osteoporosis (2014) (0)
Treatment thresholds for preventive therapy: a simplified example of therapy for prevention of hip fractures. (1996) (0)
articlePostmenopausal hormones and sleep quality in the elderly : a population based study (2015) (0)
Deep-learning-based detection of vertebral fracture and osteoporosis using lateral spine X-ray radiography. (2023) (0)
Combining quantitative and qualitative breast density measures to assess breast cancer risk (2017) (0)
Incidence and cost of vertebral fracture in urban China: A five-year population-based cohort study. (2023) (0)
The present study investigates the association between olfactory dysfunction and dementia risk among black and white older adults in the prospective Health , Aging , and Body Composition ( Health (0)
Letters to the Editor. (2016) (0)
P3-166 PPARγ Pro12Ala genotype and cognitive function in older adults: Findings from the health ABC Study (2006) (0)
Association of early-life famine exposure with low bone mass in adulthood (2023) (0)
THE PROTEOMICS OF LONGEVITY (2019) (0)
Alendronate, osteoporosis, and atherosclerosis - Reply (2008) (0)
MP04-16 URINARY INCONTINENCE IN OLDER MEN: PROSPECTIVE RELATIONSHIPS WITH BODY COMPOSITION AND MUSCLE STRENGTH IN A MULTICENTER STUDY (2018) (0)
Sex steroid hormones, bone mass and breast cancer (1998) (0)
Infection Control: The Role of Facilitator in Process Improvement To Ensure Safety of Reprocessed Medical Equipment (2007) (0)
Abstract 4060: Cystatin C and Cardiovascular Events in the Elderly: the Health, Aging, and Body Composition (Health ABC) Study (2006) (0)
7 CHANGES IN PROXIMAL FEMORAL MINERAL GEOMETRY PRECEDE THE ONSET OF RADIOGRAPHIC HIP OSTEOARTHRITIS: THE STUDY OF OSTEOPOROTIC FRACTURES (2007) (0)
Quantifying the gap between proof and practice. (2004) (0)
Deep Learning With Electronic Health Records for Short-Term Fracture Risk Identification: Crystal Bone Algorithm Development and Validation (Preprint) (2020) (0)
The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft. (2011) (0)
Association of Adolescent Exposure to Famine With Low Bone Mass in Adulthood (2022) (0)
Shape and Texture Modeling of Hip Bone Density for Fracture Discrimination. (2017) (0)
Bisphosphonates for osteoporosis and risk of breast cancer: misleading results from observational studies (2014) (0)
Activity Energy Expenditure And The Change In Body Composition During Late Life: 2548 (2008) (0)
Issues in designing and testing a "cure" for osteoporosis. (2004) (0)
Review: Smoking is associated with increased hip fracture in postmenopausal women (1998) (0)
IDENTIFICATION OF INHERITED AND ACQUIRED MITOCHONDRIAL DNA MUTATIONS LEADING TO AGE-RELATED COGNITIVE DECLINE AND DEMENTIA (2014) (0)
Fracture risk reduction with zoledronic acid by predicted fracture risk score (2011) (0)
Functional characterization of GWAS loci associated with fracture risk (2013) (0)
P-170 Aromatase gene haplotypes are associated with cognitive function in a biracial cohort of older adults: The health ABC study (2007) (0)
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism (2021) (0)
Is Breast Densitometry a Measure of Breast Cancer Risk (2001) (0)
Binocular visual field loss increases the risk of hip and non-spine, non-hip fractures (2004) (0)
Inhibition of RANKL by denosumab (2008) (0)
Response to Dr Lamy and Dr Gonzalez‐Rodriguez (2018) (0)

This paper list is powered by the following services:

Other Resources About Steven R. Cummings

en.wikipedia.org

What Schools Are Affiliated With Steven R. Cummings?

Steven R. Cummings is affiliated with the following schools: